[1] Bartlett F,Kortmann R,Saran F. Medulloblastoma. Clin Oncol(R Coll Radiol),2013,25:36-45.
[2] 黄怀忠,吕胜青,周政.髓母细胞瘤的诊治研究新进展.国际神经病学神经外科学杂志,2010,37:241-245.
[3] Louis DN,Ohgaki H,Wiestler O,et al. WHO Classification of tumours of the central nervous system. Lyon: IARC,2007.
[4] Massimino M,Antonelli M,Gandola L,et al. Histological variants of medulloblastoma are the most powerful clinical prognostic indicators. Pediatr Blood Cancer,2013,60:210-216.
[5] Chang CH,Housepian EM,Herbert Jr C. An operative staging system and a megavoltage radiotherapeutic technic for cerebellar medulloblastomas. Radiology,1969,93:1351-1359.
[6] von Hoff K,Hinkes B,Gerber NU,et al. Long-term outcome and clinical prognostic factors in children with medulloblastoma treated in the prospective randomised multicentre trial HIT′91. Eur J Cancer,2009,45:1209-1217.
[7] Rutkowski S,Bode U,Deinlein F,et al. Treatment of early childhood medulloblastoma by postoperative chemotherapy alone. N Engl J Med,2005,352:978-986.
[8] Zeltzer PM,Boyett JM,Finlay JL,et al. Metastasis stage,adjuvant treatment,and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children′s Cancer Group 921 randomized phase Ⅲ study. J Clin Oncol,1999,17:832-845.
[9] Taylor MD,Northcott PA,Korshunov A,et al. Molecular subgroups of medulloblastoma: the current consensus. Acta Neuropathol,2012,123:465-472.
[10] Gudrunardottir T,Sehested A,Juhler M,et al. Cerebellar mutism: review of the literature. Childs Nerv Syst,2011,27:355-363.
[11] Warmuth-Metz M,Bison B,Leykamm S. Neuroradiologic review in pediatric brain tumor studies. Klin Neuroradiol,2009,19:263-273.
[12] Rutkowski S,von Hoff K,Emser A,et al. Survival and prognostic factors of early childhood medulloblastoma: an international meta-analysis. J Clin Oncol,2010,28:4961-4968.
[13] Donahue B,Marymont MA,Kessel S,et al. Radiation therapy quality in CCG/POG intergroup 9961: implications for craniospinal irradiation and the posterior fossa boost in future medulloblastoma trials. Front Oncol,2012,2:185.
[14] Packer RJ,Goldwein J,Nicholson HS,et al. Treatment of children with medulloblastoma with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: a Children′s Cancer Group study. J Clin Oncol,1999,17:2127-2136.
[15] Zeltzer PM,Boyett JM,Finlay JL,et al. Metastasis stage,adjuvant treatment,and residual tumor are prognosticfactors for medulloblastoma in children: conclusionsfrom the Children′s Cancer Group 921 randomized phase Ⅲ study. J Clin Oncol,1999,17:832-845.
[16] Ashley DM,Merchant TE,Strother D,et al. Induction chemotherapy and conformal radiation therapy for very young children with nonmetastatic medulloblastoma: children′s oncology group study P9934. J Clin Oncol,2012,30:3181-3186.
[17] Massimino M,Cefalo G,Riva D,et al. Long-term results of combined preradiation chemotherapy and age-tailored radiotherapy doses for childhood medulloblastoma. J Neurooncol,2012,108:163-171.
[18] Lannering B,Rutkowski S,Doz F,et al. Hyperfractionated versus conventional radiotherapy followed by chemotherapy in standard-risk medulloblastoma: results from the randomized multicenter HIT-SIOP PNET 4 trial. J Clin Oncol,2012,30:3187-3193.
[19] Kusters JM,Louwe RJ,van Kollenburg PG,et al. Optimal normal tissue sparing in craniospinal axis irradiation using IMRT with daily intrafractionally modulated junction(s). Int J Radiat Oncol Biol Phys,2011,81:1405-1414.
[20] Blomstrand M,Brodin NP,Munck Af Rosenschld P,et al. Estimated clinical benefit of protecting neurogenesis in the developing brain during radiation therapy for pediatric medulloblastoma. Neuro Oncol,2012,14:882-889.
[21] Paulino AC,Mazloom A,Teh BS et al. Local control after craniospinal irradiation,intensity-modulated radiotherapy boost,and chemotherapy in childhood medulloblastoma. Cancer,2011,117:635-641.
[22] Taylor RE,Bailey CC,Robinson KJ,et al. Impact of radiotherapy parameters on outcome in the International Society of Paediatric Oncology/United Kingdom Children′s Cancer Study Group PNET-3 study of preradiotherapy chemotherapy for M0-M1 medulloblastoma. Int J Radiat Oncol Biol Phys,2004,58:1184-1193.
[23] Paulino AC,Lobo M,Teh BS,et al.Ototoxicity after intensity-modulated radiation therapy and cisplatin-based chemotherapy in children with medulloblastoma. int J Radiat Oncol Biol Phys,2010,78:1445-1450.
[24] Douglas JG,Barker JL,Ellenbogen RG,et al. Concurrent chemotherapy and reduced-dose cranial spinal irradiation followed by conformal posterior fossa tumor bed boost for average-risk medulloblastoma: efficacy and patterns of failure. Int J Radiat Oncol Biol Phys,2004,58:1161-1614.
[25] Polkinghorn WR,Dunkel IJ,Souweidane MM,et al. Disease control and ototoxicity using intensity-modulated radiation therapy tumor-bed boost for medulloblastoma. Int J Radiat Oncol Biol Phys,2011,81:15-20.
[26] Sung KW,Lim do H,Son MH,et al. Reduced-dose craniospinal radiotherapy followed by tandem high-dose chemotherapy and autologous stem cell transplantation in patients with high-risk medulloblastoma. Neuro Oncol,2013,15:352-359.
[27] Geyer JR,Sposto R,Jennings M,et al. Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children′s Cancer Group. J Clin Oncol,2005,23:7621-7631.
[28] Dhall G,Grodman H,Sands S,et al. Outcome of children less than three years old at diagnosis with non-metastatic medulloblastoma treated with chemotherapy on the “Head Start” I and Ⅱ protocols. Pediatr Blood Cancer,2008,50:1169-1175.
[29] Frange P,Alapetite C,Gaboriaud G,et al. From childhood to adulthood: long-term outcome of edulloblastoma patients. The Institut Curie experience(1980-2000). J Neurooncol,2009,95:271-279.
[30] Goldstein AM,Yuen J,Tucker MA. Second cancers after medulloblastoma: population-based results from the United States and Sweden. Cancer Causes Control,1997,8:865-871.
[31] Packer RJ,Zhou T,Holmes H,et al. Survival and secondary tumors in children with medulloblastoma receiving radiotherapy and adjuvant chemotherapy: results of Children′s Oncology Group trial A9961. Neuro Oncol,2013,15:97-103.
[32] Bartels U,Baruchel S,Carret AS,et al. The use and effectiveness of temozolomide in children with central nervous system tumours: a survey from the Canadian Paediatric Brain Tumour Consortium. Curr Oncol,2011,18:19-24.
[33] Jung TY,Kim CY,Kim DS,et al. Prognosis of pediatric high-grade gliomas with temozolomide treatment: a retrospective,multicenter study. Childs Nerv Syst,2012,28:1033-1039. |
|
|
2013, Vol. 22 
